Biovica International AB

STU:9II (Sweden)  
€ 0.14 (+0.44%) May 24
At Loss
P/B:
1.08
Market Cap:
€ 12.97M ($ 14.08M)
Enterprise V:
€ 4.62M ($ 5.01M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Business Description

Description
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.
Name Current Vs Industry Vs History
Cash-To-Debt 12.81
Equity-to-Asset 0.86
Debt-to-Equity 0.06
Debt-to-EBITDA -0.07
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.76
Distress
Grey
Safe
Beneish M-Score -1.93
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 66.02
9-Day RSI 54.82
14-Day RSI 48.3
6-1 Month Momentum % -43.22
12-1 Month Momentum % -76.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.27
Quick Ratio 7.1
Cash Ratio 6.77
Days Sales Outstanding 71.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.3
Shareholder Yield % 2.14

Financials (Next Earnings Date:2024-06-18)

STU:9II's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Biovica International AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.55
EPS (TTM) (€) -0.224
Beta 1.44
Volatility % 81.76
14-Day RSI 48.3
14-Day ATR (€) 0.007846
20-Day SMA (€) 0.12691
12-1 Month Momentum % -76.57
52-Week Range (€) 0.1148 - 0.829
Shares Outstanding (Mil) 84.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biovica International AB Filings

Filing Date Document Date Form
No Filing Data

Biovica International AB Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Biovica International AB Frequently Asked Questions

What is Biovica International AB(STU:9II)'s stock price today?
The current price of STU:9II is €0.14. The 52 week high of STU:9II is €0.83 and 52 week low is €0.11.
When is next earnings date of Biovica International AB(STU:9II)?
The next earnings date of Biovica International AB(STU:9II) is 2024-06-18.
Does Biovica International AB(STU:9II) pay dividends? If so, how much?
Biovica International AB(STU:9II) does not pay dividend.

Press Release

Subject Date
No Press Release